Teladoc Health Inc (NYSE:TDOC) insider Adam C. Vandervoort sold 5,549 shares of Teladoc Health stock in a transaction dated Thursday, November 8th. The shares were sold at an average price of $67.18, for a total value of $372,781.82. Following the completion of the transaction, the insider now owns 2,934 shares of the company’s stock, valued at approximately $197,106.12. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

TDOC stock opened at $62.49 on Friday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 8.99 and a current ratio of 8.99. Teladoc Health Inc has a 12-month low of $27.30 and a 12-month high of $89.05. The stock has a market capitalization of $4.79 billion, a P/E ratio of -37.87 and a beta of 0.96.

Teladoc Health (NYSE:TDOC) last issued its earnings results on Thursday, November 1st. The health services provider reported ($0.34) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.36) by $0.02. The business had revenue of $111.00 million for the quarter, compared to analysts’ expectations of $109.94 million. Teladoc Health had a negative return on equity of 14.05% and a negative net margin of 31.32%. The business’s revenue for the quarter was up 61.6% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.55) EPS. As a group, analysts expect that Teladoc Health Inc will post -1.47 earnings per share for the current year.

Several brokerages recently weighed in on TDOC. Jefferies Financial Group set a $90.00 price target on Teladoc Health and gave the company a “buy” rating in a research note on Friday, September 28th. Robert W. Baird lifted their price target on Teladoc Health from $65.00 to $80.00 and gave the company a “neutral” rating in a research note on Friday, September 28th. Canaccord Genuity lifted their price objective on Teladoc Health from $86.00 to $94.00 and gave the stock a “buy” rating in a report on Friday, September 28th. Citigroup reiterated a “buy” rating and issued a $95.00 price objective on shares of Teladoc Health in a report on Friday, September 28th. Finally, Cantor Fitzgerald lifted their price objective on Teladoc Health from $52.00 to $83.00 and gave the stock a “neutral” rating in a report on Friday, September 28th. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Buy” and an average target price of $82.95.

Several institutional investors have recently modified their holdings of the company. Oppenheimer Asset Management Inc. boosted its holdings in shares of Teladoc Health by 9.7% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 9,789 shares of the health services provider’s stock worth $845,000 after purchasing an additional 862 shares during the last quarter. CWM LLC boosted its holdings in shares of Teladoc Health by 2.1% during the 2nd quarter. CWM LLC now owns 53,632 shares of the health services provider’s stock worth $3,113,000 after purchasing an additional 1,078 shares during the last quarter. Swiss National Bank boosted its holdings in shares of Teladoc Health by 1.2% during the 3rd quarter. Swiss National Bank now owns 97,900 shares of the health services provider’s stock worth $8,454,000 after purchasing an additional 1,200 shares during the last quarter. HAP Trading LLC boosted its holdings in shares of Teladoc Health by 6.8% during the 3rd quarter. HAP Trading LLC now owns 19,650 shares of the health services provider’s stock worth $1,697,000 after purchasing an additional 1,250 shares during the last quarter. Finally, Amalgamated Bank boosted its holdings in shares of Teladoc Health by 22.3% during the 2nd quarter. Amalgamated Bank now owns 9,472 shares of the health services provider’s stock worth $550,000 after purchasing an additional 1,724 shares during the last quarter.

TRADEMARK VIOLATION WARNING: “Adam C. Vandervoort Sells 5,549 Shares of Teladoc Health Inc (TDOC) Stock” was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://theolympiareport.com/2018/11/11/adam-c-vandervoort-sells-5549-shares-of-teladoc-health-inc-tdoc-stock.html.

Teladoc Health Company Profile

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Story: How does a reverse stock split work?

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.